| | Title | Authors / Editors | Date |
|
unige:135380 |
Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results |
Zilli, Thomas; Jorcano, Sandra; Bral, Samuel; Rubio, Carmen; ... Miralbell, Raymond |
2020 |
|
unige:142944 |
Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence |
Wu, Shulin; Xie, Ling; Lin, Sharron X; Wirth, Grégory Johann; ... Wu, Chin-Lee |
2020 |
|
unige:136955 |
PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial |
De Bruycker, A.; Spiessens, A.; Dirix, P.; Koutsouvelis, N.; ... Ost, P. |
2020 |
|
unige:132971 |
Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI |
Achard, Verane; Lamanna, Giorgio; Denis, Antoine; De Perrot, Thomas Benoît; ... Zilli, Thomas |
2019 |
|
unige:136208 |
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction |
Müller, Julian; Ferraro, Daniela A.; Muehlematter, Urs J.; Garcia Schüler, Helena I.; ... Burger, Irene A. |
2019 |
|
unige:135379 |
Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice |
Panje, Cedric; Zilli, Thomas; Pra, Alan Dal; Arnold, Winfried; ... Putora, Paul Martin |
2019 |
|
unige:135381 |
Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter? |
Achard, Verane; Jorcano, Sandra; Rouzaud, Michel; Escudé, Lluís; ... Zilli, Thomas |
2019 |
|
unige:136216 |
Oligometastatic prostate cancer: The game is afoot |
Lancia, Andréa; Zilli, Thomas; Achard, Verane; Dirix, Piet; ... Ost, Piet |
2019 |
|
unige:136220 |
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial |
Zilli, Thomas; Franzese, Ciro; Bottero, Marta; Giaj-Levra, Niccolò; ... Miralbell, Raymond |
2019 |
|
unige:126250 |
First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9 |
Gnesin, Silvano; Cicone, Francesco; Mitsakis, Periklis; Van der Gucht, Axel; ... Prior, John O |
2018 |
|
unige:97434 |
Effects of age and stage on prostate cancer survival in Switzerland |
Rohrmann, Sabine; Bouchardy Magnin, Christine; Mousavi, Mohsen; Lorez, Matthias; Arndt, Volker |
2016 |
|
unige:74895 |
Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiation therapy in localized or locally-advanced prostate cancer |
Zilli, Thomas |
2015 |
|
unige:27931 |
Radical prostatectomy and pelvic lymph node dissection for organ-confined prostate cancer. Preoperative planning, surgical technique and outcomes |
Mattei, Agostino |
2013 |
|
unige:44611 |
Trends in Prostate Cancer Survival in Switzerland |
Dehler, Silvia; Rohrmann, Sabine; Lorez, Matthias; Clough-Gorr, Kerri |
2013 |
|
unige:18488 |
Combination therapy and targeted drug delivery: strategies for enhanced photodynamic therapy |
Zuluaga Estrada, Maria Fernanda |
2011 |
|
unige:17406 |
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene NKX3.1 in prostate cancer |
Kunderfranco, Paolo |
2010 |
|
unige:3777 |
Tumor suppressor role of the epithelial-specific ets transcription factor ESE-3 in prostate cancer and therapeutic implications |
Cangemi, Romina |
2008 |
|
unige:84848 |
Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologies |
Schwach, Grégoire; Oudry, Nathalie; Delhomme, Sophie; Lück, Martin; ... Gurny, Robert |
2003 |
Prostate cancer
add all
remove all
